Cytodyn Inc (CYDY)

[Black-Ops]

No , not much of a threat to Big Pharma.

Once Leronlimab is approved fot HIV Gilead will lose by my heavily researched analysis; 5 billion in revs. Oops, new numbers. Might be 7 billion. The next two years all their HIV sales as HIV Doctors spread the word.

But not much of a threat, oh no, nothing at all.

Every Billion in sales we, CYDY acquires from Big pharma CAN bring a bit less than 1$ in earnings.

Discount my number to 50 Cents per billion and own enough CYDY common that rades at 100 PE Ration; any reader might own the Dallas Cowboys someday. Now that's a visual Big Picture.